John Spertus of School of Medicine and Saint Luke’s receives Distinguished Scientist Award
John Spertus, University of Missouri-Kansas City School of Medicine professor and Daniel J. Lauer, M.D., Endowed Chair in Metabolism and Vascular Disease Research, received the American Heart Association’s 2018 Distinguished Scientist Award. Spertus also serves as clinical director of outcomes research at Saint Luke’s Mid America Heart Institute.
The award annually recognizes several prominent scientists and clinicians who have made significant and sustained contributions to advancing the understanding, management and treatment of cardiovascular disease and stroke.
Spertus developed technology that guides physicians and patients in medical-decision making by using models to measure and predict the risk factors of various procedures. Many experts cite two tools he created — the Seattle Angina Questionnaire and the Kansas City Cardiomyopathy Questionnaire — as the gold standards for measuring symptoms, function and quality of life in treating coronary artery disease and heart failure. Both have been translated into more than 95 languages.
“I am humbled by the honor to be recognized by the AHA for our work to improve the patient-centeredness of care,” Spertus said. “While traditionally the basic sciences are prioritized, to see the work of our community to improve care and outcomes is a terrific validation of the collective efforts of my entire team and colleagues.”
This is Spertus’ third major award from the American Heart Association, which he received this month at the AHA Scientific Sessions in Chicago. He previously received the organization’s Lifetime Achievement Award in 2015 and the Council on Quality of Care and Outcomes Research Distinguished Achievement Award in 2013.
“These three prominent awards reflect Dr. Spertus’ national and international stature in lifesaving health outcomes research,” said UMKC Chancellor C. Mauli Agrawal. “We are proud to have him at UMKC and fortunate that he is in our Kansas City community.”
Spertus is the founder of two outcomes research organizations. The Cardiovascular Outcomes Research Consortium and CV Outcomes is a nonprofit corporation dedicated to advancing health care quality and outcomes research in cardiovascular disease. Health Outcomes Sciences is an information technology company that implements precision medicine in clinical care.
He is currently leading a regional effort with BioNexus KC and the Frontiers Clinical and Translational Science Awards consortium to bring local hospitals together in collaboration to improve the value of health care in Kansas City.